The Brief

Health Secretary Robert F. Kennedy Jr. says the FDA will launch a safety review of the abortion pill mifepristone following a request from 22 Republican-led states.

The FDA’s decision to revisit the pill’s safety is fueling more concerns that it will be further restricted under President Donald Trump’s administration. It also highlights how the pill used in most U.S. abortions continues to be ensnared in politics that have plagued it for nearly a decade.

FDA mifepristone review

According to ABC News , Kennedy and FDA Commissioner Marty Makary are launching the review at the request of 22 Republican attorneys general.

What they're saying:

The FDA said it would conduct "its own review of the evidence, including real-world outcomes and evidence, relating to the safety

See Full Page